methods of treating, preventing or controlling a myelodysplastic syndrome, reducing or preventing an adverse effect associated with the administration of a second active ingredient in a patient suffering from a myelodysplastic syndrome, pharmaceutical composition, single unit dosage form, and kit

摘要

METHODS OF TREATMENT, PREVENTION OR CONTROL OF A MYELODISPLASTIC SYNDROME, REDUCTION OR AVOIDANCE OF AN ADVERSE EFFECT ASSOCIATED WITH ADMINISTRATION OF AN ACTIVE INGREDIENT SECOND, PATIENT UNIFIED SYNDROME, SYNDROME Methods of treatment, prevention, and / or control of myelodysplastic syndrome are described. Specific methods include administering a pharmaceutically acceptable cytokine inhibitor drug, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate or prodrug thereof, alone or in combination with a second active ingredient, and / or blood or cells for therapy. transplantation. The second specific active compounds are capable of affecting or improving blood cell production. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also described.